Virtual healthcare services, or telehealth, are rapidly becoming a standard of care in the expanding digital healthcare space ...

Novo Nordisk just killed its deal with Hims & Hers. But Hims might come out stronger after this development. Read why the ...

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

T he ad that Hims & Hers Health plans to air during the Super Bowl comes at you with rapid-fire visual overload—a giant jiggling belly, bare feet on scales, X-ray results, sugary sodas, a pie in ...

Image Source: Zacks Investment Research. Meanwhile, HIMS is trading at a forward 12-month price-to-sales (P/S) ratio of 4.6X, above its median of 2.3X over the past three years.

Hims & Hers Health (NYSE: HIMS), a telehealth platform, experienced an 8% increase in its stock on Friday, May 30th, following the announcement of a 4% reduction in its workforce.

The bundle will offer Novo Nordisk’s popular weight-loss drug at all its dosage strengths paired with a Hims & Hers membership providing "access to 24/7 care, ongoing clinical support, and ...

Novo Nordisk is ending its partnership with Hims & Hers due to concerns over its practices related to compounded GLP-1s. By Marissa Plescia on June 24, 2025 7:21 pm Share ...

Hims aims to provide accessible health care, without insurance, for an affordable price. There is no membership fee for Hims, you're only paying for your care, which can start as low as $1 per day.

Earnings Results Hims & Hers offers upbeat forecast, but stock slides after hours While shortage of GLP-1 drugs appears over, company says ‘offerings other than weight loss’ will make up most ...

The stock price of Hims & Hers Health (NYSE: HIMS), a telehealth platform, has risen a solid 14% in a week. Much of this move came after the U.S. FDA asked for more time to confirm the shortage of ...